ArticleJournal of cancer research and clinical oncology2022

Early discontinuation of induction therapy in chemoimmunotherapy as an effective alternative to the standard regimen in patients with non-small cell lung cancer: a retrospective study.

Kenji Morimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.